Indoor Radon Exposure and COPD, Synergic Association? A Multicentric, Hospital-Based Case-Control Study in a Radon-Prone Area.

COPD Case–control-studies EPOC España Estudios de casos y controles Fumar Radón residencial Residential radon Smoking Spain

Journal

Archivos de bronconeumologia
ISSN: 2173-5751
Titre abrégé: Arch Bronconeumol (Engl Ed)
Pays: Spain
ID NLM: 101777538

Informations de publication

Date de publication:
25 Dec 2020
Historique:
received: 01 10 2020
revised: 07 11 2020
accepted: 23 11 2020
entrez: 15 1 2021
pubmed: 16 1 2021
medline: 16 1 2021
Statut: aheadofprint

Résumé

COPD is a multifactorial disease which causes considerable mortality and morbidity worldwide. Previous studies assessing the possible relationship between indoor radon exposure and COPD have shown inconclusive results. A multicentric, hospital-based, case-control study was conducted in a Spanish radon-prone area. COPD cases were confirmed by spirometry and controls were selected due to trivial surgery or procedures not related to tobacco consumption. All participants had to have lived for at least 15 years in the same dwelling. Radon measurements were conducted individually in dwellings using alpha-track detectors. Results were obtained using multivariate logistic regression. 189 cases and 747 controls took part. There was no significant association between residential radon concentrations and COPD onset with a OR of 1.12 (95%CI 0.41-3.06) for individuals exposed to more than 200Bq/m No association between indoor radon and COPD has been observed. However, there might be some effect modification on the COPD risk in heavy smokers when high radon exposure is present. This is supported by the additive synergy observed. Also, a possible association between indoor radon and COPD onset in never and light smokers needs to be further studied.

Sections du résumé

BACKGROUND BACKGROUND
COPD is a multifactorial disease which causes considerable mortality and morbidity worldwide. Previous studies assessing the possible relationship between indoor radon exposure and COPD have shown inconclusive results.
METHODS METHODS
A multicentric, hospital-based, case-control study was conducted in a Spanish radon-prone area. COPD cases were confirmed by spirometry and controls were selected due to trivial surgery or procedures not related to tobacco consumption. All participants had to have lived for at least 15 years in the same dwelling. Radon measurements were conducted individually in dwellings using alpha-track detectors. Results were obtained using multivariate logistic regression.
RESULTS RESULTS
189 cases and 747 controls took part. There was no significant association between residential radon concentrations and COPD onset with a OR of 1.12 (95%CI 0.41-3.06) for individuals exposed to more than 200Bq/m
CONCLUSIONS CONCLUSIONS
No association between indoor radon and COPD has been observed. However, there might be some effect modification on the COPD risk in heavy smokers when high radon exposure is present. This is supported by the additive synergy observed. Also, a possible association between indoor radon and COPD onset in never and light smokers needs to be further studied.

Identifiants

pubmed: 33446344
pii: S0300-2896(20)30539-1
doi: 10.1016/j.arbres.2020.11.015
pii:
doi:

Types de publication

Journal Article

Langues

eng spa

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2020 SEPAR. Publicado por Elsevier España, S.L.U. All rights reserved.

Auteurs

Alberto Ruano-Ravina (A)

Department of Preventive Medicine and Public Health, University of Santiago de Compostela, Spain; Consortium for Biomedical Research in Epidemiology and Public Health (CIBER en Epidemiología y Salud Pública - CIBERESP), Spain; Health Research Institute of Santiago de Compostela (Instituto de Investigación Sanitaria de Santiago de Compostela - IDIS), Santiago de Compostela, Spain. Electronic address: alberto.ruano@usc.es.

Candela Cameselle-Lago (C)

Department of Preventive Medicine and Public Health, University of Santiago de Compostela, Spain.

María Torres-Durán (M)

Service of Neumology, University Hospital Complex of Vigo, Spain.

Ana Pando-Sandoval (A)

Service of Neumology, Central University Hospital of Asturias, Spain.

Raquel Dacal-Quintas (R)

Service of Neumology, University Hospital Complex of Ourense, Spain.

Luis Valdés-Cuadrado (L)

Service of Neumology, Clinic University Hospital of Santiago de Compostela, Santiago de Compostela, Spain.

Jesús Hernández-Hernández (J)

Service of Neumology, Ávila Hospital Complex, Ávila, Spain.

Angélica Consuegra-Vanegas (A)

Service of Neumology, A Coruña University Hospital, A Coruña, Spain.

José Andrés Tenes-Mayén (JA)

Service of Neumology, Ávila Hospital Complex, Ávila, Spain.

Leonor Varela-Lema (L)

Department of Preventive Medicine and Public Health, University of Santiago de Compostela, Spain; Consortium for Biomedical Research in Epidemiology and Public Health (CIBER en Epidemiología y Salud Pública - CIBERESP), Spain.

Alberto Fernández-Villar (A)

Service of Neumology, University Hospital Complex of Vigo, Spain.

Juan Miguel Barros-Dios (JM)

Department of Preventive Medicine and Public Health, University of Santiago de Compostela, Spain; Consortium for Biomedical Research in Epidemiology and Public Health (CIBER en Epidemiología y Salud Pública - CIBERESP), Spain; Health Research Institute of Santiago de Compostela (Instituto de Investigación Sanitaria de Santiago de Compostela - IDIS), Santiago de Compostela, Spain.

Mónica Pérez-Ríos (M)

Department of Preventive Medicine and Public Health, University of Santiago de Compostela, Spain; Consortium for Biomedical Research in Epidemiology and Public Health (CIBER en Epidemiología y Salud Pública - CIBERESP), Spain; Health Research Institute of Santiago de Compostela (Instituto de Investigación Sanitaria de Santiago de Compostela - IDIS), Santiago de Compostela, Spain.

Classifications MeSH